Erythropoietin (EPO) has protective effects against many neurological diseases, including intracerebral hemorrhage (ICH). Here, we aimed to test EPO’s effects on blood–brain barrier (BBB) disruption ...
Anemia is a frequent complication of chronic renal failure (CRF). Insufficient production of glycoprotein hormone erythropoietin (Epo) is a main causative factor of uremic anemia. Currently, regular ...
Injections of an erythropoiesis-stimulating agent (ESA), particularly darbepoetin alfa (Darbe), may eliminate or reduce the need for red blood cell transfusions in preterm infants, according to an ...
Shown is the monthly plasma concentration of erythropoietin (Panel A) and hemoglobin (Panel B) after TARGT EPO implantation in 9 of the 10 patients (the erythropoietin concentration in Patient 7 ...
CINCINNATI, Ohio — Akebia Therapeutics on Tuesday said it started its first Phase I human study (pdf) of a pill meant to help create new red blood cells in anemia patients. The drug, AKB-6548, is an ...
First Subjects Enrolled in Phase IIa Clinical Trial of EPODURE Biopumps to Treat Anemia in Patients with End-Stage Renal Disease on Dialysis MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Jul. 17, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results